• DED Assembly and Apoptosis Control in FADD Complexes

  2026-08-08

  This study defines the atomic architecture of human FADD–procaspase-8–cFLIP complexes using X-ray crystallography and cryo-electron microscopy. Its findings explain how death-effector domain assembly can produce limited caspase-8 activity that supports survival, or stronger signaling associated with apoptosis and suppression of necroptosis.

• Fingolimod: Designing Better T-Cell Trafficking Assays

  2026-08-07

  Fingolimod (FTY720) is more than an immunomodulatory agent for MS: it is a powerful variable for dissecting lymphocyte trafficking in immune-engineering studies. This article presents an assay-centered framework for separating lymphocyte egress inhibition, tumor infiltration, engineered-cell engagement, and neuroprotection via BDNF upregulation.

• TP53-Dependent DHODH Inhibition in Nasopharyngeal Carcinoma

  2026-08-07

  Dong et al. provide compelling evidence that targeting dihydroorotate dehydrogenase (DHODH) impairs nasopharyngeal carcinoma (NPC) growth through a TP53-dependent mechanism. Their integrative approach highlights nucleic acid metabolism as a promising therapeutic axis and underscores the importance of TP53 status for treatment response in NPC.

• Capsaicin in Bench Research: TRPV1 and KDM1A Inhibitor Workf

  2026-08-06

  Capsaicin ((E)-Capsaicin) is a dual-action tool for activating the TRPV1 ion channel and reversibly inhibiting KDM1A/LSD1, enabling advanced protocols in pain, inflammation, and gastric cancer research. This article delivers stepwise workflows, practical troubleshooting, and evidence-backed enhancements for maximizing reproducibility in cellular and animal models.

• Cu Single-Atom MOFs and NIR-II Imaging for Enhanced Cancer T

  2026-08-06

  This study introduces a copper single-atom-based metal-organic framework (MOF) nanoenzyme for ultrasound-enhanced chemodynamic therapy (CDT) in cancer, integrating glutathione depletion and NIR-II imaging. The findings demonstrate precise tumor targeting, efficient ROS generation, and the potential for improved molecular imaging in deep tissue environments.

• Intestinal TM6SF2 Deficiency Drives MASH via the Gut–Liver A

  2026-08-05

  The reference study demonstrates that intestinal TM6SF2 safeguards against metabolic dysfunction-associated steatohepatitis (MASH) by sustaining gut barrier integrity and microbial homeostasis. Loss of TM6SF2 in intestinal epithelial cells leads to gut barrier breakdown, dysbiosis, and hepatic inflammation, highlighting new intervention points for MASH and the importance of gut–liver crosstalk.

• BPN-19186: Applied Workflows for Signaling Pathway Modulatio

  2026-08-05

  BPN-19186 ((S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)...urea) streamlines redox and enzyme inhibition assays with high solubility and analytical purity, empowering robust research in osteoporosis, cancer, and neuroscience. Discover actionable protocols, troubleshooting insights, and translational advantages based on the latest sEH–Nrf2 axis findings.

• Carvedilol in β-Adrenergic Receptor Research: Protocols & Pi

  2026-08-04

  Carvedilol’s dual β- and α1-adrenergic receptor antagonism, paired with unique antioxidant action, makes it indispensable for cardiovascular and hematopoietic research models. This article bridges rigorous workflow optimization with the latest translational findings, equipping researchers to maximize data quality and avoid common pitfalls.

• Phosphotungstic Acid Negative Stain Solution for Virus Imagi

  2026-08-04

  Harness the power of 2% Phosphotungstic Acid Negative Stain Solution for high-contrast electron microscopy in visualizing viral glycan vulnerabilities and macromolecular architectures. This guide delivers actionable protocols and troubleshooting strategies, translating breakthrough glycoprotein-targeting research into practical laboratory workflows.

• Asunaprevir (BMS-650032): Reproducible HCV Inhibition in Cel

  2026-08-03

  This article provides laboratory researchers with scenario-driven, evidence-backed guidance for deploying Asunaprevir (BMS-650032) (SKU A3195) in cell viability and antiviral assays. Through practical Q&A blocks, it addresses common pain points, workflow optimization, and product reliability, empowering scientists to achieve robust, reproducible HCV NS3 protease inhibition. Links to protocols and supplier data are included for actionable reference.

• Perphenazine: Rethinking D2 Antagonism for Translational Imp

  2026-08-03

  This article redefines Perphenazine's role at the translational interface, bridging neuropharmacology and immunology through new mechanistic and strategic insights. By integrating data from receptor pharmacology, cell death, opioid tolerance, and host-directed antibacterial strategies, we provide actionable guidance for researchers seeking to leverage this dopamine D2 receptor antagonist across disease models. Informed by the latest primary research and cross-domain analyses, this piece surpasses conventional product summaries, offering a forward-looking, evidence-backed resource for translational scientists.

• Early Life Adversity Disrupts Innate Defensive Behavior via

  2026-08-02

  Tan et al. (2026) reveal that early life adversity (ELA) impairs visually evoked innate defensive behaviors in mice by downregulating oxytocin receptor signaling in the superior colliculus. This work clarifies a neurobiological mechanism linking early adversity to deficits in threat response, providing a theoretical foundation for future intervention strategies.

• Dual Inhibition of FUBP1 and Topoisomerase I by SN-38 in Can

  2026-08-01

  The referenced study reveals that 7-Ethyl-10-hydroxycamptothecin (SN-38), beyond its established inhibition of DNA topoisomerase I, directly disrupts the binding of oncoprotein FUBP1 to its DNA target FUSE. This dual mechanism provides new insights for advanced colon and liver cancer research where FUBP1 is overexpressed, suggesting expanded therapeutic potential for SN-38.

• Letrozole as a Molecular Probe: Precision Tools for Estrogen

  2026-07-31

  Explore the advanced scientific basis and unique advantages of Letrozole, a non-steroidal aromatase inhibitor, as a molecular probe in estrogen pathway research. This article goes beyond protocol guides, offering deep mechanistic insight and practical assay considerations for breast cancer research.

• FerroOrange: Illuminating Intracellular Fe²⁺ in Live Macroph

  2026-07-31

  Explore how FerroOrange, a leading Fe²⁺ fluorescent probe, enables advanced intracellular iron detection in live cells. This article uncovers its unique role in dissecting macrophage ferroptosis, providing deep scientific context and expert assay guidance.

458 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page